Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to compare the pharmacokinetics of nebulized amikacin administered with three vibrating mesh nebulizers coupled with a single limb circuit bilevel ventilator in healthy volunteers. Following our previous in vitro study, our hypotheses are that the pharmacokinetics varies among the devices tested and that a most efficient device can be identified.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01901497
Study type Interventional
Source University Hospital St Luc, Brussels
Contact
Status Completed
Phase N/A
Start date July 2013
Completion date January 2016

See also
  Status Clinical Trial Phase
Completed NCT02592512 - NIV-NAVA vs NIV-PS/PC in Respiratory Insufficiency N/A
Completed NCT00835809 - Multi Marker Approach Interest in Emergency in Acute Respiratory Insufficiency Diagnostic N/A
Recruiting NCT04791501 - Prevalence AND Outcome of Acute Hypoxemic Respiratory fAilure in CHILDren (PANDORA-CHILD)
Completed NCT03358043 - Prevalence and Outcome of Acute Hypoxemic Respiratory Failure in Wales
Completed NCT01931228 - Mechanical Insufflation-Exsufflation in Preventing Post Extubation Respiratory Failure in Patient With Critical Care Neuromyopathy N/A
Completed NCT03145974 - Prevalence and Outcome of Acute Hypoxemic Respiratory Failure
Completed NCT00686257 - Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure N/A
Completed NCT02939963 - Ventilation Strategies During Spontaneous Breathing Trial N/A
Completed NCT04346693 - An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19 Phase 3